Clinical Trial Update: Ph I/II Study of Allogeneic SCT for Clinically Aggressive Sickle Cell Disease (SCD) [Phase 1, Phase 2]

View source ↗

Summary

This document updates a Phase 1/2 clinical trial of allogeneic stem cell transplantation for aggressive sickle cell disease; the trial is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING